Skip to main content
. 2014 Feb 19;2014:980815. doi: 10.1155/2014/980815

Figure 2.

Figure 2

Effect of myriocin treatment (for 7 days) and streptozotocin-induced diabetes (for 7 days) on sphingomyelin (a), sphingosine (b), and sphingosine-1-phosphate (c) contents in liver homogenates. C: control group. M: group treated with myriocin. D: streptozotocin-induced diabetes group. D + M: treptozotocin-induced group treated with myriocin. Results are based on 8 independent preparations for each experimental treatment (means ± SE). *P < 0.01 compared with C group. P < 0.01 compared with D group.